Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Catalyst Pharm Inc
(NQ:
CPRX
)
16.92
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Catalyst Pharm Inc
< Previous
1
2
3
4
5
6
Next >
Why Catalyst Pharmaceuticals Shares Are Moving
March 16, 2023
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) shares are trading higher by 9.66% to $15.72 Thursday morning after the company reported better-than-expected fourth-quarter results.
Via
Benzinga
Catalyst Pharmaceuticals Earnings Perspective: Return On Capital Employed
March 16, 2023
Via
Benzinga
Catalyst Pharma The No. 1 Biotech, Just Crushed 2023 Guidance Estimates
March 15, 2023
The guidance includes Catalyst's newest, and second, product.
Via
Investor's Business Daily
Earnings Scheduled For March 15, 2023
March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
Via
Benzinga
Earnings Outlook For Catalyst Pharmaceuticals
March 14, 2023
Via
Benzinga
7 Core Stocks to Build a Solid Portfolio Around
March 13, 2023
You’ll enjoy your investing journey more if you know that you can rely on your core of stocks to buy to provide a solid foundation.
Via
InvestorPlace
2 Growth Stocks to Invest $1,000 in Right Now
March 03, 2023
Both of these biopharmas have major catalysts that are in play or drawing near.
Via
The Motley Fool
2 Breakout Growth Stocks to Buy for the Long Haul
March 03, 2023
These two stocks are entirely different, but they both make shareholders richer.
Via
The Motley Fool
7 Smart Stock Picks for Cautious Investors
February 28, 2023
As market volatility continues, consider playing it safe with these seven high-quality stocks for cautious investors.
Via
InvestorPlace
Catalyst Pharma Reveals Interim Q4 Earnings, Says Well Positioned For 2023
February 07, 2023
Via
Benzinga
Here's How Much $1000 Invested In Catalyst Pharmaceuticals 15 Years Ago Would Be Worth Today
January 25, 2023
Via
Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $27,000 Today
January 23, 2023
Via
Benzinga
Analyst Expectations for Catalyst Pharmaceuticals's Future
January 19, 2023
Via
Benzinga
The 7 Best Growth Stocks to Buy for February 2023
February 06, 2023
Some of the best growth stocks are lesser-known names that have the ability to provide tremendous long-term upside for investors.
Via
InvestorPlace
Stock Market Rally Powers Higher Amid Big Earnings From Tesla, Boeing, Microsoft, American Express: Weekly Review
January 27, 2023
Stocks reacted well to uneven earnings and economic reports.
Via
Investor's Business Daily
Down 30% in a Day, Is Catalyst Pharmaceuticals Doomed?
January 26, 2023
Things aren't as bad as they might seem.
Via
The Motley Fool
How Former IBD 50 Leader Catalyst Pharma Is Trying To Claw Back From A 29% Setback
January 25, 2023
Catalyst is adding to its portfolio with a $160 million deal.
Via
Investor's Business Daily
Nasdaq Rises 1.5%; Pliant Therapeutics Shares Spike Higher
January 23, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 150 points on Monday. The Dow traded up 0.46% to 33,527.51 while the NASDAQ rose 1.55% to 11,313.03. The...
Via
Benzinga
Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 23, 2023
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 444.4% to $1.47 after the company announced it successfully completed the review of results from Milestone 7, a phase of its...
Via
Benzinga
Dow, Nasdaq Boasting Triple-Digit Midday Lead
January 23, 2023
Investors seem intent on leaving last week's losses behind, as earnings season heats up.
Via
Talk Markets
12 Health Care Stocks Moving In Monday's Intraday Session
January 23, 2023
Via
Benzinga
Dow Jumps Over 300 Points; Crude Oil Up 1%
January 23, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 30 points on Monday. The Dow traded up 0.94% to 33,687.69 while the NASDAQ rose 1.93% to 11,355.16. The S&P 500...
Via
Benzinga
Catalyst Pharmaceuticals, Xylem And Other Big Stocks Moving Lower On Monday
January 23, 2023
U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product
January 23, 2023
Via
Benzinga
US Stocks Mostly Higher; Synchrony Financial Earnings Top Views
January 23, 2023
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 90 points on Monday.
Via
Benzinga
No. 1 IBD 50 Stock Catalyst Tanks As Teva Looks To Knock Off Its Only Product
January 23, 2023
Shares have sat atop the IBD 50 for weeks, have perfect ratings and recently hit a profit-taking zone.
Via
Investor's Business Daily
Why Catalyst Pharmaceuticals Shares Are Moving
January 23, 2023
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) shares are trading lower by 13.46% to $18.00 Monday morning after Teva Pharmaceuticals stated it plans to sell a generic version of Catalyst's FIRDAPSE in...
Via
Benzinga
IDEXX Laboratories Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
January 09, 2023
IDEXX Laboratories sees its Relative Strength Rating reach the 80-plus level.
Via
Investor's Business Daily
Top Picks For 2023: Catalyst Pharmaceuticals - Sunday, Jan. 8
January 08, 2023
For a growth-oriented choice for the new year, I'm going with under-the-radar company, Catalyst Pharmaceuticals. Let's take a look at the company's fundamentals, technicals, and institutional support...
Via
Talk Markets
Top Picks For 2023: Catalyst Pharmaceuticals
January 02, 2023
Catalyst Pharmaceuticals is a small-cap biopharma company focused on in-licensing, developing, and commercializing novel medicines to treat rare diseases. Let's take a closer look to see why it's a top...
Via
Talk Markets
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.